SCHEMBL10816643

SCHEMBL10816643

O=C(O)Cc1cc(Br)c[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
TSHR P16473 3/20 0.42
NFKB1 P19838 2/20 0.42
GABRR1 P24046 2/20 0.42
CYP3A4 P08684 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRR2 P28476 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRB2 P47870 1/20 0.42
GABRA4 P48169 1/20 0.42
PMP22 Q01453 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
ERCC1 P07992 1/20 0.41
ERCC4 Q92889 1/20 0.41
CREBBP Q92793 1/20 0.40
DAO P14920 1/20 0.40
PKM P14618 4/20 0.39
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27983276 0.75 TSHR (0.45) ALDH1A1TSHRNFKB1GABRR1CYP3A4
SCHEMBL27736998 0.75 ALDH1A1 (0.42) ALDH1A1TSHRNFKB1GABRR1CYP3A4
SCHEMBL11811837 0.75 ALDH1A1 (0.42) ALDH1A1TSHRNFKB1GABRR1CYP3A4
SCHEMBL3844258 0.75 ERCC1 (0.50) ALDH1A1TSHRNFKB1PMP22KDM4E
SCHEMBL27926108 0.72 ALDH1A1 (0.40) ALDH1A1TSHRNFKB1GABRR1CYP3A4
SCHEMBL28808887 0.71 ALDH1A1 (0.39) ALDH1A1TSHRNFKB1GABRR1CYP3A4
SCHEMBL27881202 0.69 CYP1A2 (0.46) ALDH1A1TSHRNFKB1GABRR1CYP3A4
SCHEMBL27797182 0.68 TDP1 (0.38) ALDH1A1TSHRNFKB1GABRR1CYP3A4
SCHEMBL2472805 0.68 ALDH1A1 (0.50) ALDH1A1CYP3A4MAPTHPGDCYP2C9
SCHEMBL1928760 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105658652-A Compositions useful for treating disorders associated with KIT 蓝图药品公司 2016-06-08 CN disclosed
CN-103391940-A As dual activity H1Inverse agonist/5-HT2ASubstituted [ (5H-pyrrolo [2 ] s) of antagonists LILLY CO ELI 2013-11-13 CN disclosed
CN-101223161-A Heteroaryl derivatives for treating viruses GENELABS TECH INC (US) 2008-07-16 CN disclosed
CN-101027305-A Fused heterocyclic kinase inhibitors BRISTOL MYERS SQUIBB CO (US) 2007-08-29 CN disclosed
EP-0114632-B1 5-(4-VINYL- OR 4-ETHYNYLBENZOYL)-1,2-DIHYDRO-3H-PYRROLO-(1,2-A)-PYRROLE-1-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF SYNTEX (U.S.A.) INC. (US) 1987-09-16 EP disclosed
US-4560699-A ANTIPYRETICS, ANTICOAGULANTS, VASODILAAORS, MUSCLE RELAXANTS SYNTEX (U.S.A.) INC. (US) 1985-12-24 US disclosed
EP-0041711-B1 6-CHLORO- OR 6-BROMO-1,2-DIHYDRO-3H-PYRROLO(1,2-A)-PYRROLE-1-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYNTEX (U.S.A.) INC. (US) 1985-04-17 EP disclosed
EP-0114632-A1 5-(4-Vinyl- or 4-ethynylbenzoyl)-1,2-dihydro-3H-pyrrolo-(1,2-A)-pyrrole-1-carboxylic acids and derivatives thereof SYNTEX (U.S.A.) INC. (US) 1984-08-01 EP disclosed
US-4344943-A ANALGESICS, ANTIINFLAMMATORY AGENTS SYNTEX (U.S.A.) INC. (US) 1982-08-17 US disclosed
EP-0041711-A1 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo(1,2-a)-pyrrole-1-carboxylic acids and derivatives thereof, process for their production and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1981-12-16 EP disclosed